Журнал «Здоровье ребенка» Том 20, №4, 2025
Вернуться к номеру
Постінфекційний синдром подразненого кишечника у дітей: шляхи корекції
Авторы: Шадрін О.Г., Горянська М.Г.
ДУ «Всеукраїнський центр материнства та дитинства НАМН України», м. Київ, Україна
Рубрики: Педиатрия/Неонатология
Разделы: Справочник специалиста
Версия для печати
Серед захворювань шлунково-кишкового тракту у дітей чільне місце займає постінфекційний синдром подразненого кишечника (ПІ-СПК), який діагностується на основі Римських критеріїв IV перегляду. Для діагностики ПІ-СПК важливими є наявність рецидивуючих болів у животі, асоційованих зі зміною характеру дефекацій, пов’язаних з попереднім епізодом гострого інфекційного гастроентериту. Патогенез ПІ-СПК є багатофакторним та включає зміни в кишковому мікробіомі, кишковому епітелії, імунну дисрегуляцію та зміни в нейрональному збудженні. Експертна оцінка застосування комбінації Saccharomyces boulardii та цинку в комплексній терапії дітей 7–12 років з діарейною формою ПІ-СПК свідчила про нормалізацію кратності та характеру випорожнень, усунення абдомінального больового синдрому, метеоризму у 89,2 % дітей.
Among gastrointestinal diseases in children, the leading place belongs to the post-infectious irritable bowel syndrome (PI-IBS), which is diagnosed based on the Rome IV criteria. For the diagnosis of PI-IBS, the presence of recurrent abdominal pain associated with a change in the nature of defecation due to a previous episode of acute infectious gastroenteritis is important. The pathogenesis of PI-IBS is multifactorial and includes changes in the intestinal microbiome, intestinal epithelium, immune dysregulation, and in neuronal excitation. Expert assessment of the use of a combination of Saccharomyces boulardii and zinc in the comprehensive therapy of children aged 7–12 years with diarrheal form of PI-IBS showed normalization of the frequency and nature of bowel movements, elimination of abdominal pain syndrome, and flatulence in 89.2 % of children.
синдром подразненого кишечника; діти; Saccharomyces boulardii
irritable bowel syndrome; children; Saccharomyces boulardii
- Abbas Z, Yakoob J, Jafri W, Ahmad Z, Azam Z, Usman MW, et al. Cytokine and clinical response to Saccharomyces boulardii therapy in diarrhea-dominant irritable bowel syndrome: a randomized trial. Eur J Gastroenterol Hepatol. 2014;26:630-639.
- Abdulah DM, Sulaiman SJ, Ahmed ZW. Effect of probiotics plus zinc supplementation on clinical outcomes of infants and children with acute infectious diarrhea: a randomized controlled trial. Clin Exp Pediatr. 2024 Apr;67(4):203-212. doi: 10.3345/cep.2023.01340.
- Barbara G, Grover M, Bercik P, et al. Rome Foundation working team report on post-infection irritable bowel syndrome. Gastroenterology. 2019;156:46-58e7.
- Вerumen A, Lennon R, Breen-Lyles M, et al. Characteristics and risk factors of post-infection irritable bowel syndrome following Campylobacter enteritis. Clin Gastroenterol Hepatol. 2020. July 22;S1542-3565(20)30995-2.
- Berumen A, Edwinson AL, Grover M. Post-infection Irritable Bowel Syndrome. Gastroenterol Clin North Am. 2021 Jun;50(2):445-461. doi: 10.1016/j.gtc.2021.02.007. Epub 2021 Apr 23.
- Chao HC. Zinc Deficiency and Therapeutic Value of Zinc Supplementation in Pediatric Gastrointestinal Diseases. Nutrients. 2023 Sep 22;15(19):4093. doi: 10.3390/nu15194093.
- Chen J, Zhang Y, Deng Z. Imbalanced shift of cytokine expression between T helper 1 and T helper 2 (Th1/Th2) in intestinal mucosa of patients with post-infectious irritable bowel syndrome. BMC Gastroenterol. 2012;12:91.
- Czerucka D, Rampal P. Effect of Saccharomyces boulardii on cAMP- and Ca2+-dependent Cl- Secretion in T84 Cells. Dig Dis Sci. 1999;44:2359-2368. https://doi.org/10.1023/A:1026689628136.
- Dicksved J, Ellstrom P, Engstrand L, et al. Susceptibility to Campylobacter infection is associated with the species composition of the human fecal microbiota. mBio. 2014;5:e01212-14.
- Drossman DA, Hasler WL. Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction. Gastroenterology. 2016;150:1257-1261.
- Dunlop SP, Jenkins D, Neal KR, et al. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology. 2003;125:1651-59.
- Dunlop SP, Hebden J, Campbell E, et al. Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes. Am J Gastroenterol. 2006;101:1288-94.
- Edogawa S, Edwinson AL, Peters SA, et al. Serine proteases as luminal mediators of intestinal barrier dysfunction and symptom severity in IBS. Gut. 2020;69:62.
- Farsi F, Zonooz SR, Ebrahimi Z, Jebraili H, Morvaridi M, Azimi T, et al. The Incidence of Post-infectious Irritable Bowel Syndrome, Anxiety, and Depression in Iranian Patients with Coronavirus Disease 2019 Pandemic: A Cross-Sectional Study. Turk J Gastroenterol. 2022;33:1033-1042.
- Halmos EP, Power VA, Shepherd SJ, et al. A diet low in –FODMAPs reduces symptoms of irritable bowel syndrome. Gastroentero–logy. 2014;146:67-75e5.
- Jalanka J, Salonen A, Fuentes S, et al. Microbial signatures in post-infectious irritable bowel syndrome — toward patient stratification for improved diagnostics and treatment. Gut Microbes. 2015;6:364-9.
- Khan NM. To determine outcome of probiotics in treatment of acute diarrhoea in children. Pakistan J Med Health Sci. 2021;15:1829-31.
- Klem F, Wadhwa A, Prokop LJ, et al. Prevalence, risk factors, and outcomes of irritable bowel syndrome after infectious enteritis: A systematic review and meta-analysis. Gastroenterology. 2017;152:1042-54e1.
- Koren O, Tako E. Chronic Dietary Zinc Deficiency Alters Gut Microbiota Composition and Function. Proceedings. 2020;61(1):16. https://doi.org/10.3390/IECN2020-06993.
- Kulkarni H, Mamtani M, Patel A. Roles of zinc in the pathophysiology of acute diarrhea. Curr Infect Dis Rep. 2012;14:24-32. doi: 10.1007/s11908-011-0222-8.
- Li Z, Zhu G, Li C, et al. Which probiotic is the most effective for treating acute diarrhea in children? A Bayesian network meta-analysis of randomized controlled trials. Nutrients. 2021;13:4319.
- Long Y, Du L, Kim JJ, et al. MLCK-mediated intestinal permeability promotes immune activation and visceral hypersensitivity in PI-IBS mice. Neurogastroenterol Motil. 2018;30:e13348.
- Maares M, Keil C, Straubing S, Robbe-Masselot C, Haase H. Zinc Deficiency Disturbs Mucin Expression, O-Glycosylation and Secretion by Intestinal Goblet Cells. Int. J. Mol. Sci. 2020;21:6149. doi: 10.3390/ijms21176149.
- Mari A, Abu Baker F, Mahamid M, Sbeit W, Khoury T. The Evol–ving Role of Gut Microbiota in the Management of Irritable Bowel Syndrome: An Overview of the Current Knowledge. J Clin Med. 2020 Mar 4;9(3):685.
- Matheis F, Muller PA, Graves CL, et al. Adrenergic signaling in muscularis macrophages limits infection-induced neuronal loss. Cell. 2020;180:64-78e16.
- Mearin F, Lacy BE, Chang L, et al. Bowel disorders. Gastroenterology. 2016 Feb 18;S0016-5085(16)00222-5.
- Miyoshi Y, Tanabe S, Suzuki T. Cellular zinc is required for intestinal epithelial barrier maintenance via the regulation of claudin-3 and occludin expression. Am. J. Physiol. Gastrointest. Liver Physiol. 2016;311:G105-G116. doi: 10.1152/ajpgi.00405.2015.
- Mourey F, Sureja V, Kheni D, et al. A multicenter, rando–mized, double-blind, placebo-controlled trial of Saccharomyces boulardii in infants and children with acute diarrhea. Pediatr Infect Dis J. 2020;39:e347-51.
- Muller PA, Schneeberger M, Matheis F, et al. Microbiota modulate sympathetic neurons via a gut–brain circuit. Nature. 2020;583:441-6.
- Niaz SK, Sandrasegaran K, Renny FH, et al. Postinfective diarrhoea and bile acid malabsorption. J R Coll Physicians Lond. 1997;31:53-6.
- Patel A, Mamtani M, Dibley MJ, Badhoniya N, Kulkarni H. Therapeutic value of zinc supplementation in acute and persistent diarrhea: A systematic review. PLoS ONE. 2010;5:e10386. doi: 10.1371/journal.pone.0010386.
- Settanni CR, Ianiro G, Ponziani FR, Bibbò S, Segal JP, Cammarota G, Gasbarrini A. COVID-19 as a trigger of irritable bowel syndrome: A review of potential mechanisms. World J Gastroenterol. 2021;27:7433-7445.
- Sundin J, Rangel I, Repsilber D, et al. Cytokine response after stimulation with key commensal bacteria differ in post-infectious irritable bowel syndrome (PI-IBS) patients compared to healthy controls. PLоS ONE. 2015;10:e0134836.
- Szajewska H, Guarino A, Hojsak I, et al. Use of probiotics for the management of acute gastroenteritis in children: an update. J Pediatr Gastroenterol Nutr. 2020;71:261-9.
- Tooth D, Garsed K, Singh G, et al. Characterisation of faecal protease activity in irritable bowel syndrome with diarrhoea: origin and effect of gut transit. Gut. 2014;63:753-60.
- Vahjen W, Pieper R, Zentek J. Bar-coded pyrosequencing of 16S rRNA gene amplicons reveals changes in ileal porcine bacterial communities due to high dietary zinc intake. Appl Environ Microbiol. 2010 Oct;76(19):6689-91. doi: 10.1128/AEM.03075-09.
- Veiga-Fernandes H, Mucida D. Neuro-immune interactions at barrier surfaces. Cell. 2016;165:801-11.
- Villani AC, Lemire M, Thabane M, et al. Genetic risk factors for post-infectious irritable bowel syndrome following a waterborne outbreak of gastroenteritis. Gastroenterology. 2010;138:1502-13.
- Wan Y, Zhang B. The Impact of Zinc and Zinc Homeostasis on the Intestinal Mucosal Barrier and Intestinal Diseases. Biomolecules. 2022 Jun 27;12(7):900. doi: 10.3390/biom12070900.